Cell Isolation Market

The report "Cell Isolation Market/Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031" The Cell Isolation Market is expected to reach USD 7.97 billion in 2031 from USD 4.39 billion in 2026, at a CAGR of 12.7% during the forecast period.

Browse 630 market data Tables and 30 Figures spread through 470 Pages and in-depth TOC on "Cell Isolation Market/Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html

The cell isolation market is experiencing significant growth, driven by the expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, and increasing use of automated and closed isolation systems. Pharmaceutical and biotechnology companies are increasingly using cell isolation technologies for immune cell enrichment, stem cell research, cancer biology, biomarker discovery, and translational research. The shift toward GMP-grade cell isolation products is further supporting market expansion, particularly as cell therapy developers require high-purity, viable, and reproducible cell populations for clinical and manufacturing applications. However, the market continues to face challenges, including the high cost of instruments and consumables, loss of cell viability or recovery during isolation, and difficulties in scaling research workflows for GMP manufacturing.

By cell type, the human cells segment held the largest share of the cell isolation market in 2025.

By cell type, the cell isolation market is segmented into human cells and animal cells. In 2025, human cells accounted for the largest market share. This is primarily due to the high demand for human-derived immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells across drug discovery, translational research, cell and gene therapy development, cancer biology, and clinical diagnostics. Human cell isolation is widely used in immunology studies, biomarker validation, personalized medicine, and therapeutic development, where biologically relevant human samples are essential for accurate research outcomes. The growing adoption of single-cell analysis, immune profiling, and GMP-compatible cell therapy workflows further supports the dominance of the human cells segment in the market.

By instruments, the centrifuges segment held the largest share of the cell isolation market in 2025.

By instruments, the cell isolation market is segmented into centrifuges, cell sorters, magnetic-activated cell separator systems, filtration systems, and other instruments. In 2025, centrifuges accounted for the largest market share. This is due to their widespread use in routine cell separation, sample preparation, density gradient centrifugation, washing, pelleting, and enrichment workflows. Centrifuges are commonly used across academic laboratories, biotechnology companies, pharmaceutical research facilities, clinical laboratories, and cell processing units because they are cost-effective, scalable, and compatible with multiple sample types. Their continued use in peripheral blood mononuclear cell isolation, leukocyte separation, stem cell enrichment, and primary cell preparation supports their leading position in the instruments segment.

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the cell isolation market. This is supported by a strong biopharmaceutical base, early adoption of advanced cell-separation technologies, substantial investment in cell and gene therapy research, and well-established biomedical research infrastructure. The US leads the region in immunology research, oncology studies, stem cell research, single-cell analysis, and clinical cell therapy development. The presence of major market players, cell therapy companies, academic medical centers, clinical laboratories, and specialized research institutes continues to drive demand for cell isolation products. Ongoing advancements in automated cell isolation, closed-system processing, and GMP-grade consumables are further supporting market growth in North America.

Some of the leading players in the market include Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US), among others.

Don’t miss out on business opportunities in Cell Isolation Market/Cell Separation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]